These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9501783)

  • 1. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Grupo Argentino de Estudio de Placenta Retenida.
    Carroli G; Belizan JM; Grant A; Gonzalez L; Campodonico L; Bergel E
    Br J Obstet Gynaecol; 1998 Feb; 105(2):179-85. PubMed ID: 9501783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2001; (4):CD001337. PubMed ID: 11687109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical vein injection for management of retained placenta.
    Kumar N; Jahanfar S; Haas DM; Weeks AD
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001337. PubMed ID: 33705565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical vein injection for management of retained placenta.
    Nardin JM; Weeks A; Carroli G
    Cochrane Database Syst Rev; 2011 May; (5):CD001337. PubMed ID: 21563129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical vein injection for the routine management of third stage of labour.
    Mori R; Nardin JM; Yamamoto N; Carroli G; Weeks A
    Cochrane Database Syst Rev; 2012 Mar; (3):CD006176. PubMed ID: 22419311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?
    Lim PS; Singh S; Lee A; Muhammad Yassin MA
    Arch Gynecol Obstet; 2011 Nov; 284(5):1073-9. PubMed ID: 21136267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a place for intra-umbilical oxytocin for the management of retained placenta?
    Sivalingam N; Surinder S
    Med J Malaysia; 2001 Dec; 56(4):451-9. PubMed ID: 12014765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-umbilical vein injection of carbetocin versus oxytocin in the management of retained placenta.
    Salem MAA; Saraya YS; Badr MS; Soliman AM
    Sex Reprod Healthc; 2019 Oct; 21():21-25. PubMed ID: 31395229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial.
    Gazvani MR; Luckas MJ; Drakeley AJ; Emery SJ; Alfirevic Z; Walkinshaw SA
    Obstet Gynecol; 1998 Feb; 91(2):203-7. PubMed ID: 9469276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial.
    Weeks AD; Alia G; Vernon G; Namayanja A; Gosakan R; Majeed T; Hart A; Jafri H; Nardin J; Carroli G; Fairlie F; Raashid Y; Mirembe F; Alfirevic Z
    Lancet; 2010 Jan; 375(9709):141-7. PubMed ID: 20004013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial.
    Samanta A; Roy SG; Mistri PK; Mitra A; Pal R; Naskar A; Bhattacharya SK; Pal PP; Pande A
    J Obstet Gynaecol Res; 2013 Jan; 39(1):75-82. PubMed ID: 22889466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbetocin versus intra-umbilical oxytocin in the management of retained placenta: a randomized clinical study.
    Elfayomy AK
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1207-13. PubMed ID: 25976063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical vein injection of misoprostol versus normal saline for the treatment of retained placenta: intrapartum placebo-controlled trial.
    Rajab SS; Alalaf SK
    BMC Pregnancy Childbirth; 2014 Jan; 14():37. PubMed ID: 24444360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?
    Huber MG; Wildschut HI; Boer K; Kleiverda G; Hoek FJ
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1216-9. PubMed ID: 1709781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial.
    Güngördük K; Asicioglu O; Besimoglu B; Güngördük OC; Yildirm G; Ark C; Tekirdağ AI
    Obstet Gynecol; 2010 Sep; 116(3):619-624. PubMed ID: 20733444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intraumbilical vein oxytocin injection on third stage of labor.
    Nankali A; Keshavarzi F; Fakheri T; Zare S; Rezaei M; Daeichin S
    Taiwan J Obstet Gynecol; 2013 Mar; 52(1):57-60. PubMed ID: 23548219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth.
    Soltani H; Hutchon DR; Poulose TA
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006173. PubMed ID: 20687079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.